Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraosseous Hypertonic Saline in Acute Brain Injury
NCT03276494Phase 2Completed
- Sponsor
- The Ohio State University
- Start
- Apr 2017
- Primary completion
- Apr 2018
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of hypertonic saline in cerebral edema and intracranial hypertension (IH), sponsored by The Ohio State University. Primary endpoint: Number of Subjects With Tissue Damage at 24 hours. Started Apr 2017; status: completed.
02
Drugs
hypertonic saline
03
Conditions
cerebral edemaintracranial hypertension (IH)
Beyond the preview
Go deeper on NCT03276494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03276494.